G673-0140 Screening compound: 5-{[(2,3-dihydro-1,4-benzodioxin-6-yl)carbamoyl]methyl}-N,N-dimethyl-6-oxo-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxaline-3-carboxamide

G673-0140 Screening compound: 5-{[(2,3-dihydro-1,4-benzodioxin-6-yl)carbamoyl]methyl}-N,N-dimethyl-6-oxo-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxaline-3-carboxamide
G673-0140 Screening compound: 5-{[(2,3-dihydro-1,4-benzodioxin-6-yl)carbamoyl]methyl}-N,N-dimethyl-6-oxo-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxaline-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G673-0140
5-{[(2,3-dihydro-1,4-benzodioxin-6-yl)carbamoyl]methyl}-N,N-dimethyl-6-oxo-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxaline-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G673-0140

Molecular Formula

C25H28N4O5 (C25 H28 N4 O5)

Compound Name

5-{[(2,3-dihydro-1,4-benzodioxin-6-yl)carbamoyl]methyl}-N,N-dimethyl-6-oxo-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxaline-3-carboxamide

IUPAC name

5-{[(23-dihydro-14-benzodioxin-6-yl)carbamoyl]methyl}-NN-dimethyl-6-oxo-5H6H6aH7H8H9H10H-pyrido[12-a]quinoxaline-3-carboxamide

SMILES

CN(C)C(c(cc1)cc(N2CC(Nc(cc3)cc4c3OCCO4)=O)c1N(CCCC1)C1C2=O)=O

InChI

InChI=1S/C25H28N4O5/c1-27(2)24(31)16-6-8-18-20(13-16)29(25(32)19-5-3-4-10-28(18)19)15-23(30)26-17-7-9-21-22(14-17)34-12-11-33-21/h6-9,13-14,19H,3-5,10-12,15H2,1-2H3,(H,26,30)/t19-/m0/s1

InChI Key

MIHABVQRDIEODT-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27150428

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.52

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.546

Distribution Coefficient, logD

0.546

Water Solubility, LogSw

-2.24

Polar Surface Area

72.765

Acid Dissociation Constant (pKa)

11.21

Base Dissociation Constant (pKb)

2.64

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.00

G673-0140 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system

References: we are preparing a list of scientific research reports with G673-0140 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G673-0140?
Check Price and Availability of G673-0140, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G673-0140 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G673-0140
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G673-0140
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G673-0140 available by request